<prompt> Mechanism of action of Exenatide:SGLT inhibitorGLP-1 AnalogueDPP4 inhibitorAMP kinase inhibitor  <response>: Ref: Goodman Gillman 13th ed. P 877 GLP-1 analogue drugs are: Exenatide, Liraglutide, Albiglutide, Dulaglutide, Lixisenatide These agents activate the GLP-1 receptor - Increased insulin biosynthesis and release These agents are resistant to degradation by DPP4 enzyme - Has extended activity following injection. Side effect: Nausea, vomiting, Pancreatitis Properties of insulin secretagoguesClass Generic nameDaily Dosage mgDuration of Action hours or dosing frequencySulfonylureasGlimepiride1-824Glipizide5-4012-18Glipizide extended release5-2024Glyburide1.25-2012-24Glyburide micronized0.75-1212-24Nonsulfonylureas MeglitinidesNateglinide180-3602-4Repaglinide0.5-162-6GLP-1 AgonistsAlbiglutide30-50WeeklyDulaglutide0.75-1.5WeeklyExenatideb2WeeklyLiraglutide0.6-1.8DailyLixisenatide0.010-0.020DailyDipeptidyl Peptidase-4 InhibitorsAlogliptin25DailyLinagliptin5DailySaxagliptin2.5-5DailySitagliptin25-10012-16Vildagliptin50-100Twice daily 